U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301151) titled 'PASCAL Feasibility Study' on Dec. 11.
Brief Summary: The goal of this randomized study is to assess if a conversational agent (or chatbot) that the investigators have developed to help with quitting smoking is acceptable to people trying to quit smoking and to also collect initial information regarding its effectiveness.
In this study, some participants trying to quit smoking will be provided with this chatbot while other participants will not be
Study Start Date: Jan. 15, 2026
Study Type: INTERVENTIONAL
Condition:
Smoking Cessation
Smoking (Tobacco) Addiction
Intervention:
OTHER: chatbot
a chatbot will alert during predicte...